HIGHLIGHTS
- who: Yuexiao Qi from the Sun Yat-sen University Cancer Center (SYSUCC), China have published the paper: An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer, in the Journal: (JOURNAL) of December/31,/2021
- what: Among them, 62 studies were excluded for the following reasons: 15 studies lacked outcomes of interest, 14 studies were just trial protocols (study designs) without study results, 14 studies referred to second-line treatments; 10 studies were single-arm studies, five trials included . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.